Adult-onset focal expression of mutated human tau in the hippocampus impairs spatial working memory of rats

Behavioural Brain Research

Volumn 233, Issue 1, 2012, Pages 141-148

  Mustroph, Martina L ^a,e   King, Michael A ^b,c   Klein, Ronald L ^d   Ramirez, Julio J ^a  

^a DAVIDSON COLLEGE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^e UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

AAV; Hippocampus; Learning; Memory; P301L; Tauopathy

Indexed keywords

ADENOVIRUS VECTOR; TAU PROTEIN;

ADULT ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE; GENE EXPRESSION; GENE TRANSFER; HIPPOCAMPUS; MALE; MEMORY DISORDER; NEUROFIBRILLARY TANGLE; NONHUMAN; PRIORITY JOURNAL; RAT; SPATIAL MEMORY; TASK PERFORMANCE; TAU GENE; TAUOPATHY; WORKING MEMORY;

ANALYSIS OF VARIANCE; ANIMALS; CELL DEATH; DISEASE MODELS, ANIMAL; GENETIC VECTORS; GLIAL FIBRILLARY ACIDIC PROTEIN; GREEN FLUORESCENT PROTEINS; HIPPOCAMPUS; HUMANS; MALE; MEMORY DISORDERS; MEMORY, SHORT-TERM; MUTATION; NEUROFIBRILLARY TANGLES; NEUROFILAMENT PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; SPACE PERCEPTION; TAU PROTEINS; TAUOPATHIES;

EID: 84861545750     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2012.04.034     Document Type: Article

References (68)

1. Caselli R.J., Beach T.G., Yaari R., Reiman E.M. Alzheimer's disease a century later. The Journal of Clinical Psychiatry 2006, 67:1784-1800.
2. Kawabata S., Higgins G.A., Gordon J.W. Amyloid plaques, neurofibrillary tangles and neuronal loss in brains of transgenic mice overexpressing a C-terminal fragment of human amyloid precursor protein. Nature 1991, 354:476-478.
3. Bucciantini M., Giannoni E., Chiti F., Baroni F., Formigli L., Zurdo J., et al. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 2002, 416:507-511.
4. Chen G., Chen K.S., Knox J., Inglis J., Bernard A., Martin S.J., et al. A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease. Nature 2000, 408:975-979.
5. Janus C., Pearson J., McLaurin J., Mathews P.M., Jiang Y., Schmidt S.D., et al. A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature 2000, 408:979-982.
6. Lashuel H.A., Hartley D., Petre B.M., Walz T., Lansbury P.T. Neurodegenerative disease: amyloid pores from pathogenic mutations. Nature 2002, 418:291.
7. Morgan D., Diamond D.M., Gottschall P.E., Ugen K.E., Dickey C., Hardy J., et al. A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature 2000, 408:982-985.
8. Schenk D., Barbour R., Dunn W., Gordon G., Grajeda H., Guido T., et al. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 1999, 400:173-177.
9. Brunden K.R., Trojanowski J.Q., Lee V.M. Evidence that non-fibrillar tau causes pathology linked to neurodegeneration and behavioral impairments. Journal of Alzheimer's Disease 2008, 14:393-399.
10. Ittner L.M., Ke Y.D., Delerue F., Bi M., Gladbach A., van Eersel J., et al. Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models. Cell 2010, 142:387-397.
11. Joseph J., Shukitt-Hale B., Denisova N.A., Martin A., Perry G., Smith M.A. Copernicus revisited: amyloid beta in Alzheimer's disease. Neurobiology of Aging 2001, 22:131-146.
12. Ramirez J.J., Poulton W.E., Knelson E., Barton C., King M.A., Klein R.L. Focal expression of mutated tau in entorhinal cortex neurons of rats impairs spatial working memory. Behavioural Brain Research 2011, 216:332-340.
13. Vogelsberg-Ragaglia V., Schuck T., Trojanowski J.Q., Lee V.M. PP2A mRNA expression is quantitatively decreased in Alzheimer's disease hippocampus. Experimental Neurology 2001, 168:402-412.
14. Gendron T.F., Petrucelli L. The role of tau in neurodegeneration. Molecular Neurodegeneration 2009, 4:13.
15. Hanger D.P., Betts J.C., Loviny T.L., Blackstock W.P., Anderton B.H. New phosphorylation sites identified in hyperphosphorylated tau (paired helical filament-tau) from Alzheimer's disease brain using nanoelectrospray mass spectrometry. Journal of Neurochemistry 1998, 71:2465-2476.
16. Hanger D.P., Byers H.L., Wray S., Leung K.Y., Saxton M.J., Seereeram A., et al. Novel phosphorylation sites in tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis. The Journal of Biological Chemistry 2007, 282:23645-23654.
17. Lebouvier T., Scales T.M., Williamson R., Noble W., Duyckaerts C., Hanger D.P., et al. The microtubule-associated protein tau is also phosphorylated on tyrosine. Journal of Alzheimer's Disease 2009, 18:1-9.
18. Noble W., Hanger D.P., Gallo J.M. Transgenic mouse models of tauopathy in drug discovery. CNS & Neurological Disorders - Drug Targets 2010, 9:403-428.
19. Takashima A. Hyperphosphorylated tau is a cause of neuronal dysfunction in tauopathy. Journal of Alzheimer's Disease 2008, 14:371-375.
20. Wray S., Saxton M., Anderton B.H., Hanger D.P. Direct analysis of tau from PSP brain identifies new phosphorylation sites and a major fragment of N-terminally cleaved tau containing four microtubule-binding repeats. Journal of Neurochemistry 2008, 105:2343-2352.
21. Duyckaerts C., Hauw J.J. Diagnosis and staging of Alzheimer disease. Neurobiology of Aging 1997, 18:S33-S42.
22. Nagy Z., Esiri M.M., Jobst K.A., Morris J.H., King E.M., McDonald B., et al. Relative roles of plaques and tangles in the dementia of Alzheimer's disease: correlations using three sets of neuropathological criteria. Dementia 1995, 6:21-31.
23. Adamec E., Murrell J.R., Takao M., Hobbs W., Nixon R.A., Ghetti B., et al. P301L tauopathy: confocal immunofluorescence study of perinuclear aggregation of the mutated protein. Journal of the Neurological Sciences 2002, 200:85-93.
24. Arendash G.W., Lewis J., Leighty R.E., McGowan E., Cracchiolo J.R., Hutton M., et al. Multi-metric behavioral comparison of APPsw and P301L models for Alzheimer's disease: linkage of poorer cognitive performance to tau pathology in forebrain. Brain Research 2004, 1012:29-41.
25. Klein R.L., Lin W.L., Dickson D.W., Lewis J., Hutton M., Duff K., et al. Rapid neurofibrillary tangle formation after localized gene transfer of mutated tau. American Journal of Pathology 2004, 164:347-353.
26. Ramsden M., Kotilinek L., Forster C., Paulson J., McGowan E., SantaCruz K., et al. Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L). The Journal of Neuroscience 2005, 25:10637-10647.
27. Santacruz K., Lewis J., Spires T., Paulson J., Kotilinek L., Ingelsson M., et al. Tau suppression in a neurodegenerative mouse model improves memory function. Science 2005, 309:476-481.
28. Spires T.L., Orne J.D., SantaCruz K., Pitstick R., Carlson G.A., Ashe K.H., et al. Region-specific dissociation of neuronal loss and neurofibrillary pathology in a mouse model of tauopathy. American Journal of Pathology 2006, 168:1598-1607.
29. Hrnkova M., Zilka N., Minichova Z., Koson P., Novak M. Neurodegeneration caused by expression of human truncated tau leads to progressive neurobehavioural impairment in transgenic rats. Brain Research 2007, 1130:206-213.
30. Korhonen P., van Groen T., Thornell A., Kyrylenko S., Soininen M.L., Ojala J., et al. Characterization of a novel transgenic rat carrying human tau with mutation P301L. Neurobiology of Aging 2010, 32:2314-2315.
31. Zilka N., Filipcik P., Koson P., Fialova L., Skrabana R., Zilkova M., et al. Truncated tau from sporadic Alzheimer's disease suffices to drive neurofibrillary degeneration in vivo. FEBS Letters 2006, 580:3582-3588.
32. Gao G., Vandenberghe L.H., Alvira M.R., Lu Y., Calcedo R., Zhou X., et al. Clades of Adeno-associated viruses are widely disseminated in human tissues. Journal of Virology 2004, 78:6381-6388.
33. Cearley C.N., Wolfe J.H. Transduction characteristics of adeno-associated virus vectors expressing cap serotypes 7, 8, 9, and Rh10 in the mouse brain. Molecular Therapy 2006, 13:528-537.
34. Klein R.L., Dayton R.D., Tatom J.B., Henderson K.M., Henning P.P. AAV8, 9, Rh10, Rh43 vector gene transfer in the rat brain: effects of serotype, promoter and purification method. Molecular Therapy 2008, 16:89-96.
35. Klein R.L., Dayton R.D., Lin W.L., Dickson D.W. Tau gene transfer, but not alpha-synuclein, induces both progressive dopamine neuron degeneration and rotational behavior in the rat. Neurobiology of Disease 2005, 20:64-73.
36. Klein R.L., Dayton R.D., Tatom J.B., Diaczynsky C.G., Salvatore M.F. Tau expression levels from various adeno-associated virus vector serotypes produce graded neurodegenerative disease states. The European Journal of Neuroscience 2008, 27:1615-1625.
37. Klein R.L., Dayton R.D., Terry T.L., Vascoe C., Sunderland J.J., Tainter K.H. PET imaging in rats to discern temporal onset differences between 6-hydroxydopamine and tau gene vector neurodegeneration models. Brain Research 2009, 1259:113-122.
38. Gotz J., Chen F., Barmettler R., Nitsch R.M. Tau filament formation in transgenic mice expressing P301L tau. The Journal of Biological Chemistry 2001, 276:529-534.
39. Lewis J., McGowan E., Rockwood J., Melrose H., Nacharaju P., Van Slegtenhorst M., et al. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nature Genetics 2000, 25:402-405.
40. Murakami T., Paitel E., Kawarabayashi T., Ikeda M., Chishti M.A., Janus C., et al. Cortical neuronal and glial pathology in TgTauP301L transgenic mice: neuronal degeneration, memory disturbance, and phenotypic variation. American Journal of Pathology 2006, 169:1365-1375.
41. Terwel D., Lasrado R., Snauwaert J., Vandeweert E., Van Haesendonck C., Borghgraef P., et al. Changed conformation of mutant Tau-P301L underlies the moribund tauopathy, absent in progressive, nonlethal axonopathy of Tau-4R/2N transgenic mice. The Journal of Biological Chemistry 2005, 280:3963-3973.
42. Graham K.S., Hodges J.R. Differentiating the roles of the hippocampal complex and the neocortex in long-term memory storage: evidence from the study of semantic dementia and Alzheimer's disease. Neuropsychology 1997, 11:77-89.
43. Izquierdo I., Medina J.H., Vianna M.R., Izquierdo L.A., Barros D.M. Separate mechanisms for short- and long-term memory. Behavioural Brain Research 1999, 103:1-11.
44. Jarrard L.E. On the role of the hippocampus in learning and memory in the rat. Behavioral and Neural Biology 1993, 60:9-26.
45. Martin S.J., Clark R.E. The rodent hippocampus and spatial memory: from synapses to systems. Cellular and Molecular Life Sciences 2007, 64:401-431.
46. Parkin A.J. Human memory: the hippocampus is the key. Current Biology 1996, 6:1583-1585.
47. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathologica 1991, 82:239-259.
48. Apostolova L.G., Dutton R.A., Dinov I.D., Hayashi K.M., Toga A.W., Cummings J.L., et al. Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps. Archives of Neurology 2006, 63:693-699.
49. Scheff S.W., Price D.A. Alzheimer's disease-related alterations in synaptic density: neocortex and hippocampus. Journal of Alzheimer's Disease 2006, 9:101-115.
50. Stewart S., Cacucci F., Lever C. Which memory task for my mouse? A systematic review of spatial memory performance in the Tg2576 Alzheimer's mouse model. Journal of Alzheimer's Disease 2011, 26:105-126.
51. Hughes R.N. The value of spontaneous alternation behavior (SAB) as a test of retention in pharmacological investigations of memory. Neuroscience and Biobehavioral Reviews 2004, 28:497-505.
52. Ramirez J.J., Campbell D., Poulton W., Barton C., Swails J., Geghman K., et al. Bilateral entorhinal cortex lesions impair acquisition of delayed spatial alternation in rats. Neurobiology of Learning and Memory 2007, 87:264-268.
53. Ramirez J.J., Stein D.G. Sparing and recovery of spatial alternation performance after entorhinal cortex lesions in rats. Behavioural Brain Research 1984, 13:53-61.
54. Hutton M., Lendon C.L., Rizzu P., Baker M., Froelich S., Houlden H., et al. Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998, 393:702-705.
55. Spillantini M.G., Crowther R.A., Kamphorst W., Heutink P., van Swieten J.C. Tau pathology in two Dutch families with mutations in the microtubule-binding region of tau. American Journal of Pathology 1998, 153:1359-1363.
56. Klein R.L., Dayton R.D., Leidenheimer N.J., Jansen K., Golde T.E., Zweig R.M. Efficient neuronal gene transfer with AAV8 leads to neurotoxic levels of tau or green fluorescent proteins. Molecular Therapy 2006, 13:517-527.
57. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1986, Academic Press, New York.
58. Morgan D., Munireddy S., Alamed J., DeLeon J., Diamond D.M., Bickford P., et al. Apparent behavioral benefits of tau overexpression in P301L tau transgenic mice. Journal of Alzheimer's Disease 2008, 15:605-614.
59. Klein R.L., Wang D.B., King M.A. Versatile somatic gene transfer for modeling neurodegenerative diseases. Neurotoxicity Research 2009, 16:329-342.
60. Liu L., Drouet V., Wu J.W., Witter M.P., Small S.A., Clelland C., et al. Trans-synaptic spread of tau pathology in vivo. PloS one 2012, 7:e31302.
61. de Calignon A., Polydoro M., Suarez-Calvet M., William C., Adamowicz D.H., Kopeikina K.J., et al. Propagation of tau pathology in a model of early Alzheimer's disease. Neuron 2012, 73:685-697.
62. Kim W., Lee S., Jung C., Ahmed A., Lee G., Hall G.F. Interneuronal transfer of human tau between Lamprey central neurons in situ. Journal of Alzheimer's Disease 2010, 19:647-664.
63. Wang D.B., Dayton R.D., Zweig R.M., Klein R.L. Transcriptome analysis of a tau overexpression model in rats implicates an early pro-inflammatory response. Experimental Neurology 2010, 224:197-206.
64. Neher J.J., Neniskyte U., Brown G.C. Primary phagocytosis of neurons by inflamed microglia: potential roles in neurodegeneration. Frontiers in Pharmacology 2012, 3:27.
65. Graeber M.B., Streit W.J., Kiefer R., Schoen S.W., Kreutzberg G.W. New expression of myelomonocytic antigens by microglia and perivascular cells following lethal motor neuron injury. Journal of Neuroimmunology 1990, 27:121-132.
66. Prinz M., Priller J., Sisodia S.S., Ransohoff R.M. Heterogeneity of CNS myeloid cells and their roles in neurodegeneration. Nature Neuroscience 2011, 14:1227-1235.
67. Fukushima T., Nakamura A., Iwakami N., Nakada Y., Hattori H., Hoki S., et al. T-817MA, a neuroprotective agent, attenuates the motor and cognitive impairments associated with neuronal degeneration in P301L tau transgenic mice. Biochemical and Biophysical Research Communications 2011, 407:730-734.
68. Pennanen L., Wolfer D.P., Nitsch R.M., Gotz J. Impaired spatial reference memory and increased exploratory behavior in P301L tau transgenic mice. Genes, Brain and Behavior 2006, 5:369-379.